# EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions

> **NCT01435031** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 250 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)
- Chronic Total Occlusion (CTO)

## Interventions

- **DEVICE:** CTO Treatment Device

## Key facts

- **NCT ID:** NCT01435031
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-02
- **Final completion:** 2017-12
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435031, "EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01435031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*